Stuart “Stu” Barich joined Canccord Genuity in 2025 as Managing Director and Head of Biotechnology in our US Healthcare Investment Banking group. Stuart has 30+ years of experience in investment banking, focusing on Life Sciences, most recently spending a decade at Raymond James, where he was Managing Director. He has participated in the successful completion of over 520 transactions during his career, covering a broad spectrum of equity and mergers and acquisitions. Prior to joining Raymond James, Stuart spent almost 10 years at Oppenheimer and five years at Leerink Swann completing numerous transactions for Biotechnology and Specialty Pharmaceutical companies. He previously directed the healthcare banking efforts at Oscar Gruss & Son and Auerbach, after beginning his career as a Corporate Finance Associate with Paine Webber.
Stuart has a BS in electrical engineering from the University of Rochester and an MBA with honors from Columbia Business School.